References
- Martin W. R., Gorodetzky C. W., McClane T. K. Presented to Committee on Problems of Drug Dependence. National Research Council. 1965
- Wilder A. Narcotics, D. M. Wiener, G. C. Kasselbaum. McGraw-Hill, New York 1965; 85–100
- Jaffe J. H., Brill L. Int. J. Addict. 1966; 1: 99–123
- Chapel J. N., Senay E. C, Jaffe J. H. Q. J. Addict. 1971; 6: 509–523
- Fink M., Zaks A., Sharoff R., Mora A., Bruner A., Levit S., Freedman A. M. Clin. Pharmacol. Ther. 1968; 9: 568–577
- Zaks A., Jones T., Fink M., Freedman A. M. Naloxone treatment of opiate dependence. J. Am. Med. Assoc. March 29, 1971; 215(13)
- Martin W. R., Jasinski D. R., Mansky P. A. Arch. Gen. Psychiatry 1973; 28: 784–791
- Resnick R. B., Volavka J., Freedman A. M., Jones T., Thomas M. J. J Am. Psychiatr. Assoc, in press
- Schecter A., Grossman D. Experiences with naltrexone: A suggested role in drug abuse treatment programs. Proceedings of the First National Drug Abuse Conference. 1974
- Schecter A., Grossman D. Clinical study of naltrexone: Preliminary observations. Drug addiction, Neurotherapy and Other Treatment, J. Singh. Vol. 5, In Press
- Schecter A., Friedman J., Grossman D. Clinical use of naltrexone (EN-1639A): Efficacy and safety in pilot studies. Am. J. Drug Alcohol Abuse 1974; 1(2)253–269
- N.I.D.A. Sponsored Narcotic Antagonist Conference. Seattle, Washington September/October, 1974